Koh M - Search Results

1

Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit.

Nickles E, Dharmadhikari B, Yating L, Walsh RJ, Koh LP, Poon M, Tan LK, Wang LZ, Ang Y, Asokumaran Y, Chong WQ, Huang Y, Loh KS, Tay J, Soo R, Koh M, Ho LP, Chan M, Niam M, Soh M, Luah YH, Lim CM, Kaliaperumal N, Au VB, Talib NBSN, Sng R, Connolly JE, Goh BC, Schwarz H. Nickles E, et al. Among authors: koh lp, koh m. Cancer Immunol Immunother. 2022 Jun;71(6):1531-1543. doi: 10.1007/s00262-021-03075-3. Epub 2021 Oct 18. Cancer Immunol Immunother. 2022. PMID: 34661709 Free PMC article. Clinical Trial.

2

Severe conidiobolomycosis complicating induction chemotherapy in a patient with acute lymphoblastic leukaemia.

Tan DC, Hsu LY, Koh LP, Goh YT, Koh M. Tan DC, et al. Among authors: koh lp, koh m. Br J Haematol. 2005 May;129(4):447. doi: 10.1111/j.1365-2141.2005.05429.x. Br J Haematol. 2005. PMID: 15877726 Free article. No abstract available.

3

KHYG-1 and NK-92 represent different subtypes of LFA-1-mediated NK cell adhesiveness.

Suck G, Tan SM, Chu S, Niam M, Vararattanavech A, Lim TJ, Koh MB. Suck G, et al. Among authors: koh mb. Front Biosci (Elite Ed). 2011 Jan 1;3(1):166-78. doi: 10.2741/e230. Front Biosci (Elite Ed). 2011. PMID: 21196295 Free article.

4

Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignancies.

Suck G, Oei VY, Linn YC, Ho SH, Chu S, Choong A, Niam M, Koh MB. Suck G, et al. Among authors: koh mb. Exp Hematol. 2011 Sep;39(9):904-14. doi: 10.1016/j.exphem.2011.06.003. Epub 2011 Jun 13. Exp Hematol. 2011. PMID: 21703984 Free article.

5

Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy.

Niam M, Linn YC, Fook Chong S, Lim TJ, Chu S, Choong A, Yong HX, Suck G, Chan M, Koh M. Niam M, et al. Among authors: koh m. Exp Hematol. 2011 Sep;39(9):897-903.e1. doi: 10.1016/j.exphem.2011.06.005. Epub 2011 Jun 16. Exp Hematol. 2011. PMID: 21703986 Free article.

6

The anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignancies.

Linn YC, Niam M, Chu S, Choong A, Yong HX, Heng KK, Hwang W, Loh Y, Goh YT, Suck G, Chan M, Koh M. Linn YC, et al. Among authors: koh m. Bone Marrow Transplant. 2012 Jul;47(7):957-66. doi: 10.1038/bmt.2011.202. Epub 2011 Oct 10. Bone Marrow Transplant. 2012. PMID: 21986635 Clinical Trial.

7

A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission.

Linn YC, Yong HX, Niam M, Lim TJ, Chu S, Choong A, Chuah C, Goh YT, Hwang W, Loh Y, Ng HJ, Suck G, Chan M, Koh M. Linn YC, et al. Among authors: koh m. Cytotherapy. 2012 Aug;14(7):851-9. doi: 10.3109/14653249.2012.694419. Cytotherapy. 2012. PMID: 22799277 Clinical Trial.

8

Thirty Years of Bone Marrow Transplantation in the Singapore General Hospital.

Phipps C, Ho AY, Linn YC, Gopalakrishnan S, Ang AL, Lee JJ, Ng HY, Lim FW, Goh PS, Loh YS, Tan PH, Koh LP, Koh MB, Lee LH, Goh YT, Ong YW, Hwang WY. Phipps C, et al. Ann Acad Med Singap. 2016 Jul;45(7):315-7. Ann Acad Med Singap. 2016. PMID: 27523512 Free article. No abstract available.

9

A novel simplified method of generating cytomegalovirus-specific cytokine-induced killer cells of high specificity and superior potency with GMP compliance.

Luah YH, Sundar Raj K, Koh MBC, Linn YC. Luah YH, et al. Clin Immunol. 2019 Aug;205:83-92. doi: 10.1016/j.clim.2019.06.007. Epub 2019 Jun 21. Clin Immunol. 2019. PMID: 31229666

10

Multicenter study of comparative outcomes of hematopoietic stem cell transplant for peripheral T cell lymphoma and natural killer/T-cell lymphoma.

Hwang WY, Koh LP, Lim ST, Linn YC, Loh YS, Koh MB, Diong CP, Lee JJ, Zhang XH, Rajgor D, Gandhi M, Shah A, Goh YT. Hwang WY, et al. Among authors: koh lp, koh mb. Leuk Lymphoma. 2011 Jul;52(7):1382-6. doi: 10.3109/10428194.2011.569038. Epub 2011 May 23. Leuk Lymphoma. 2011. PMID: 21599577 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,190 results

Search Page

Filters